Newborn with Metabolic Disease
are Most Severe and can Lead to Death

Metabolism is a set of chemical reaction processes, in which enzymes play an important role in breaking down and converting food into energy to maintain the body’s operation, such as the immune system, physical development and brain development, etc.; it can also digest food Get energy to ensure proper functioning of the body.

Newborn infants with metabolic diseases (congenital metabolic deficiencies) due to the lack of some enzymes for normal metabolic function, the body accumulates too many toxic substances or lacks important nutrients. Although metabolic diseases are relatively rare, if proper treatment is not performed in time, metabolic diseases can lead to disability in the limbs, lifelong disabilities, and intellectual disability. In the most serious cases, it can lead to death.

An Affected Baby may Appear Normal

Newborns with metabolic disorders may not show any sign or symptoms at birth. It is likely undetected or misled to other diagnosis. Screening your newborn will facilitate early intervention and prevent long term detrimental effects to your baby’s health such as such as mental retardation, physical disability and in some instances, death, if it is left untreated.


Disclaimer

Metascreen is a trademark or registered trademark of Cordlife Group Limited, a Singapore Exchange Mainboard listed company. The screening test offered under the brand is conducted by Cordlife (Hong Kong) Ltd., a CAP-accredited laboratory committed to providing early and accurate detection of metabolic disorders in newborn babies. Cordlife (Hong Kong) Ltd. has a quality management system in place to ensure maximum accuracy of screening results. As with any laboratory tests, false positive or false negative results cannot be completely eliminated due to various reasons including but not limited to age of patient at the time of specimen collection, patient’s health status, specimen quality and other variables. Hence, the risk of a disorder should never be precluded solely on the basis of screening. Signs or symptoms observed should be followed up immediately by a professional healthcare provider.

Reference :
1) This cumulative incidence rate is based on the Meta 100+ panel.